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The immune response to phosphorylchotine (PC) 1 in BALB/c mice is domi- 
nated by a single antibody specificity (clonotype) which is identical to TEPC 15 
(T15) and several other BALB/c myeloma proteins by the criteria of idiotypic 
cross-reaction and  isoelectric focusing (1-5).  Bone marrow-derived antibody- 
forming cell precursors (B cells) specific for PC have been found at a frequency 
of approximately 1/50,000 splenic B cells, of which 20-25% is not of the T15 
clonotype (6). 
The analysis of the response to PC as well  as responses to other antigens has been 
greatly facilitated by the availability of antibody probes which are specific for immuno- 
globulin variable region idiotypic determinants. These anti-idiotypic sera have been used 
to investigate the mechanism of immune responsiveness (7, 8), the heterogeneity of the 
B-cell repertoire (3, 9-11), and the genetic information corresponding to immunoglobulin 
structure (12-14). In general, anti-idiotypic antibody is raised by immunization of synge- 
neic,  allogeneic, or xenogeneic animals with a  myeloma protein or a  highly restricted 
antibody. After removal of antibodies which are directed against aUotypic and constant 
region determinants of the immunoglobulins, the remaining antibodies have the ability 
to recognize variable region determinants. However, these antibodies are heterogeneous 
and may differ greatly in their recognition of sites (e.g.,  combining sites vs. framework 
regions) and in their ability to discriminate between antibodies which differ by only a few 
amino acids (11, 15). 
Recently, two types of anti-idiotypic sera which are reactive against T15 have been 
developed. Immunization of A/He mice with T15 yields a murine anti-idiotypic antibody 
(M anti-T15) which recognizes anti-PC antibodies of  mice that express the Ig-l" heavy chain 
allotype. The binding of M anti-T15 to T15 is minimally inhibited by hapten; thus, the 
anti-idiotype either  binds  the  PC-combining site  with  a  very high  affinity  (7)  or is 
directed at variable region framework determinants outside the antibody-combining site 
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(13, 16). In  addition,  Claflin and  Davie  (16) have described the preparation  of anti- 
idiotypic antibody to HOPC 8, a protein idiotypically indistinguishable from T15, which is 
produced in rabbits and purified by adsorption to a HOPC 8 immunoadsorbent, followed 
by elution  with  PC.  Since the  binding of this  anti-idiotypic antibody to  HOPC 8  is 
completely inhibited  by free hapten,  it  appears to be directed  against  determinants 
within the antigen-combining site. Rabbit anti-HOPC 8 was found to react with anti-PC 
antibody from severa] al]otypical|y diverse murine strains. This observation, in combina- 
tion with the M anti-Tl5 findings, implied that although the framework regions may 
vary between strains,  the  combining site itself may be highly conserved within the 
species (17). 
We have prepared a  rabbit anti-idiotypic antibody to T15 (R anti-T15) with 
hapten-modifiable properties similar to rabbit anti-HOPC 8. The availability of 
two  anti-idiotypic  antibody  populations,  M  anti-T15  and  R  anti-T15,  which 
recognize different portions  of the  variable region,  has  permitted  a  detailed 
analysis  of the murine  PC-specific repertoire.  First,  the findings indicate the 
existence of a heterogeneous population of B cells within the BALB/c PC-specific 
repertoire.  Second,  2% of the detectable BALB/c PC-specific monoclonal anti- 
bodies  reacted  strongly  with  R  anti-T15,  but  very weakly  with  M  anti-T15. 
Third, the total frequency of cells specific for PC in A/He, AKR, and C3H mice 
was slightly lower than the BALB/c l~equency. Fourth, although the three non- 
BALB/c strains produced monoclonal antibodies that were completely reactive 
with R anti-T15, such clones represented a minority of the nonimmune precur- 
sor cells; there does not appear to be a  dominant clonotype expressed in the B 
cells of these strains.  Furthermore, a  minority of monoclonal antibodies which 
were derived from AKR B cells reacted as well with M anti-T15 and R anti-T15 
as did BALB/c monoclonal antibodies. Thus, the use of anti-idiotypic reagents 
that can identify distinctive cross-reactivities within heterogeneous precursor 
cell  repertoires  has  permitted  the  recognition  and  analysis  of a  variety  of 
clonotypes which neither occur in unusually high frequency nor dominate the 
population of responding cells. The identification of similar combining sites on 
different variable region frameworks within the same strain and the sharing of 
similar combining sites and frameworks among murine strains are discussed in 
terms  of the  regulation  of expression of the  immunoglobulin  variable  region 
gene pool. 
Materials  and  Methods 
Animals  and Antigens.  6-8-wk-old BALB/c AnN, A/He, C3H, and AKR mice were obtained 
from the Institute for Cancer Research, Philadelphia, Pa. AKR/J mice were also purchased from The 
Jackson  Laboratory,  Bar Harbor,  Maine.  New Zealand  white  rabbits were  purchased  from 
Skippack Farms, Skippack, Pa. The preparation of hemocyanin (Hy), phosphorylcholine-Hy (PC- 
Hy), and 3-(p-azophenylphosphorylcholine)-N-acetyl-L-tyrosyl-glycylglycine Boc hydrazide-hemo- 
cyanin (PPC-TGG-Hy) have been described previously (3, 6). 
Plasmacytoma Proteins and lmmunoadsorbents.  The plasma cell tumors T15 and MOPC 460 
were obtained  from Dr.  M.  Potter, National  Cancer  Institute, National Institutes of Health, 
Bethesda, Md., and maintained by serial passage in BALB/c mice. Partially reduced and alkyl- 
ated T15 ascites fluid was purified by acid elution from a PC-glycyltyrosine-Sepharose 4B (Phar- 
macia Fine Chemicals,  Inc.,  Piscataway,  N. J.) column (18), and MOPC 460 was purified by 
adsorption  to 2,4-dinitrophenyl-lysine-Sepharose  4B and eluted with 0.5 N HC1 (19). Purified 
MOPC 167, McPC 603, and MOPC 511 proteins, with specificity for PC, were the generous gift of 
Dr. Stuart Rudikoff, National Institutes of Health.  T15, McPC 603, and MOPC 460 were conju- 878  MONOCLONAL  ANTI-PHOSPHORYLCHOLINE  ANTIBODY  RESPONSE 
gated to Sepharose 4B by the procedure of Cuatrecasas (20).  The preparation of PC-bovine serum 
albumin (BSA)-bromoacetyl cellulose has been described previously (3). 
Immunizations.  BALB/c mice were immunized intraperitoneally with 0.1 mg of H~ in complete 
Freund's adjuvant 2-3 mo before use as recipients in spleen cell transfer experiments. Mice to be 
used as immune donors received 0.1 mg of PC-Hy or PPC-TGG-Hy in complete Freund's adjuvant 
and were used 2-4 mo later. 
A/He mice were immunized with purified T15 or McPC 603 protein according to the protocol of 
Lieberman and Humphrey (21).  Serum from individual mice which was specific for each idiotype 
was used in this work. Two rabbits were immunized with 1 mg of T15 protein in complete Freund's 
adjuvant in eight subcutaneous sites and 1 mo later with 1 mg of T15 in incomplete Freund's 
adjuvant in the same sites. The rabbits were bled weekly and the injection and bleeding schedule 
was repeated 2 mo later. The sera from both rabbits showed similar patterns of hapten inhibition 
and reactivity with clonal antibody and thus were used interchangeably. 
Purification ofAnti-Idiotypic  Sera.  Anti-T15 sera or anti-McPC 603 sera from A/He mice were 
diluted 1:10 with 0.02 phosphate-0.15 M NaC1 buffer solution, pH 7.4, and passed through a MOPC 
460-Sepharose column. R anti-T15 which was specific for the antigen-combining site was prepared 
according to Clafiin and Davie (16). The serum was diluted 1:1 with 0.05 M berate buffer plus 0.15 
M NaC1, pH 8.3, and passed through a column of T15-Sepharose. Then R anti-T15 was eluted with 
10  -z M PC in borate-saline buffer, and repassed over the T15 column, which was equilibrated with 
10  -3 M  PC.  The eluate was extensively dialyzed against borate-buffered saline and then passed 
over a  McPC 603 Sepharose column, dialyzed, and concentrated by pervaporation. 
Splenic Focus Technique.  Spleen cell preparations from donor mice were prepared by teasing 
the cells out of the spleen into Dulbecco's modified Eagle's medium. The cells were 80-90% viable. 
20  ×  108 cells  from nonimmune donors  and 5  ×  106  cells from  immune  donors  were  injected 
intravenously into syngeneic Hy-primed recipients that  had been irradiated with 1,300 R  6  h 
earlier. Fragment cultures were prepared from spleens of recipient mice 16 h after cell transfer, as 
described previously (22). The fragments were individually stimulated in culture with PPC-TGG- 
Hy (5  ×  10  -7 M hapten), and culture fluids were changed every 2-3 days. Fluids collected 10-15 
days after stimulation were assayed for anti-hapten antibody, heavy chain isotype, and idiotype. 
Radioimmunoassays  for Antibody  and Idiotype.  20 /~l of culture fluid was added to PC-BSA- 
bromoacetyl cellulose and bound anti-hapten antibody was detected by the subsequent binding of 
l~SI-labeled purified rabbit anti-mouse Fab antibody or ~5I-labeled purified goat antibody against 
mouse p-, T1- or  a-heavy chain constant region determinants (3).  The amount of antibody was 
quantified in the anti-Fab assay using T15 protein as a standard. T15, McPC 603, MOPC 167, and 
MOPC 511 all produced similar binding curves with the immunoadsorbent. 
Idiotypic assays were performed by initially determining the dilution of anti-idiotypic antibody 
that produced maximal control binding and inhibition. The M  anti-T15 sera used in this study 
were diluted 1:6,000  in phosphate-saline buffer, and the anti-McPC 603 sera were diluted 1:3,000. 
Binding  of  T15  by  purified  R  anti-T15  antibody  was  linearly  related  to  the  dilution  made. 
Generally,  a  dilution that bound  10%  of the added 125I-labeled  T15 protein was used with the 
addition of 0.017%  normal  rabbit serum.  1  ml  of the  appropriate  dilution of anti-idiotype  was 
added to 10 ×  75-mm polystyrene test tubes (Falcon Products, Becton, Dickinson & Co., Cockeys- 
ville, Md.) and incubated for 4 h  at room temperature. The serum was withdrawn and the tubes 
were washed with 1 ml of phosphate-buffered saline. Then 1 ml of phosphate buffer containing 1% 
BSA was added, and the tubes were incubated for 30 min at room temperature. The solution was 
removed and 20 ~1 of various concentrations of unlabeled inhibitor proteins or culture fluids was 
added, followed by the addition of 1.1 ml of 1% BSA in phosphate-buffered saline containing 2 ng of 
~SI-labeled T15 protein, with a  specific activity of 15-20 ktCi/~tg  protein (23).  After incubation at 
37°C for 18 h, the tubes were washed three times with phosphate-buffered saline and counted in a 
gamma counter. 
Hapten and Antigen Inhibition.  In the radioimmunoassay for antibody, solutions of the hapten, 
PC in 0.15 M  NaC1  (saline), or the antigen, PC-Hy, were preincubated with myeloma protein or 
culture fluids for 1 h  at room temperature. The mixture was then added to PC-BSA-bromoacetyl 
cellulose such that the final concentration of free  hapten or the  haptenic determinant on the 
carrier was as specified in Table I.  After 1 h, the tubes were centrifuged and washed; then ~zsI- 
labeled anti-Fab was added to the pellet, and the procedure was continued as described previously 
(23). In the assay for idiotype, hapten or antigen was preincubated with ~zSI-labeled T15 for 1 h and P.  J.  GEARHART,  N.  H.  SIGAL,  AJqD  N.  R.  KLINMAN  879 
TABLE I 
Specificity of Anti-Idiotypic  Antibodies 
Inhibition of ~I-la-  Inhibition 
beled T15 binding to  of 12~I-lao 
beled McPC 
603 binding 
M anti- 
R anti-T15  to anti- 
T15 
McPC 603 
Inhibitor* 
%  % 
T15  5 ng  44  66  0 
50 ng  85  90  0 
McPC 603  50 ng  0  0  82 
MOPC 167  50 ng  0  0  0 
10 -3 M PC  0  77  17 
10 -5 M PC-Hy  57  73  71 
* Unlabeled protein, hapten, or antigen was added as an inhibitor in the 
binding of 2  ng  of ~2~I-labeled  idiotype to  anti-idiotype-coated test 
tubes. 
then added to tubes coated with anti-idiotypic antibody. Afar 1 h  incubation at 37°C with frequent 
mixing, the tubes were washed and gamma emissions were counted. 
Results 
Specificity of  Anti-Idiotypic Antibodies.  Both M anti-T15 and R anti-T15 were 
specifically inhibited from binding ~2~I-labeled T15 by unlabeled T15, but not by 
two other PC-binding myeloma proteins, McPC 603 and MOPC  167. As seen in 
Table I, the M anti-T15 used in this study was not inhibited from binding T15 in 
the presence of free hapten, although PC-Hy was an effective inhibitor. R anti- 
T15, on the other hand, was effectively  blocked from binding T15 by PC. Although 
both anti-idiotypes are heterogeneous antibody mixtures, the hapten inhibition 
data indicates that a majority of antibody in the R anti-T15 preparation can be 
generally classified as antigen-combining  site-specific, whereas M anti-T15 may 
contain primarily antibody either with an affinity too high to be inhibited by 
hapten or directed against variable region determinants surrounding, but not 
in, the hapten-combining site. 
In addition, the specificity of A/He anti-McPC 603 serum is shown in Table I. 
The anti-idiotype is specific  for McPC  603, and the reaction is inhibited to a 
greater extent with PC-Hy than with the free hapten. 
Anti-PC Frequency in Murine Strains.  The frequency  of B cells specific for PC 
from nonimmune and  immune donors representing four murine strains  was 
calculated using donor-cell homing and stimulation efficiencies previously de- 
scribed for BALB/c mice (24) (Table II). We have previously shown that the in 
vitro anti-PC response is maximized by using PC linked via a tripeptide spacer 
to the carrier (3). The overall frequency of cells specific for PC is only slightly 
lower in AKR, C3H, and A]He mice than that previously reported for the BALB/c 
strain  (6). However, the total frequency of precursors responsive to PC  (1 in 
43,000-120,000 nonimmune B cells) is much lower than the frequency of cells 
that are specific for dinitrophenyl (1 in 5,000 cells) (22). Immunization with PC- 
Hy increased the frequency severalfold, which suggests the potential for the 
generation of a memory cell pool to even an ubiquitous antigen. 880  MONOCLONAL  ANTI-PHOSPHORYLCHOLINE  ANTIBODY  RESPONSE 
TABLE  II 
Frequency of PC-Specific B  Cells in Nonimmune and Immune 
Mice 
Strain 
Number of clones/106 B cells* 
Nonimmune  Immune$ 
BALB/c  23.2  91.7 
AKR  9.1  49.2 
A/He  8.5  52.7 
C3H  12.5  18.6 
* 276-924  x  106 cells from 11 to 23 nonimmune donor mice were sub- 
jected to clonal analysis, and 50-720 ×  108 cells from 4 to 14 immune 
mice were examined. 
$ Mice were  immunized with  PC-Hy 2-4  mo before use as donors in 
splenic loci experiments. 
Characterization of Clonotypes.  Monoclonal anti-PC antibodies derived from 
B cells of the four mouse strains were analyzed for the presence or absence of M 
anti-T15 and R  anti-T15 reactivity.  A description of the major clonotypes that 
are delineated by the two anti-T15 sera is given in Table III. In BALB/c mice, 
four types of antibodies were distinguished:  (a) monoclonal antibodies quantita- 
tively  reactive  with  both  R  anti-T15  and  M  anti-T15  (R  T15+,  M  T15+), 
representing  the  dominant,  i.e.,  T15,  clonotype identified  previously  (6); (b) 
monoclonal  antibodies  not reactive with  either  M  anti-T15  or  R  anti-T15  (R 
T15-, M T15-);  (c) antibodies partially reactive in varying degrees with both 
anti-idiotypes  (R T15_  +,  M T15_+); and  (d) monoclonal antibodies significantly 
more reactive with R anti-T15 than with M anti-T15 on a weight basis. Antibod- 
ies in this latter group were divided into two subgroups: those reactive with R 
anti-T15 but not M anti-T15  (R T15+, M T15-),  and those completely reactive 
with R anti-T15, when compared to Fab content, but only partially reactive with 
M anti-T15 (R T15+, M T15_). The cross-reactivity found with some antibodies 
in the latter group with M anti-T15 may be due to the presence in M anti-T15 of 
a  minor  fraction of antibodies with specificity for the antigen-binding  site, or 
alternatively,  may reflect cross-reactivity of some framework determinants. 
In AKR mice, one group of clones reacted equally well when assayed by anti- 
Fab,  M  anti-T15,  and  R  anti-T15,  and  thus  was  indistinguishable  by these 
criteria  from the  R  T15+,  M  T15+  clonotype in the  BALB/c strain.  Another 
group  of AKR monoclonal  antibodies  did not react with either  anti-idiotypic 
antisera,  and a third group reacted partially with both antisera.  A/He and C3H 
B cells produced monoclonal antibodies which were either:  (a) equally reactive 
with anti-Fab and R anti-T15 but not with M anti-T15,  (R T15+, M T15-),  (b) 
nonreactive with both anti-idiotypic antisera (R T15-, M T15-), or (c) partially 
reactive with either or both antisera  (R T15+_, M T15_+). 
Analysis ofBALB/c Clonotype  Heterogeneity.  An analysis of the reactivity of 
approximately 700 monoclonal antibodies from nonimmune and immune BALB/c 
donors  with  anti-Fab,  M  anti-T15,  and  R  anti-T15  has  been  schematically 
represented in Fig.  la and 1 b as the ratio of the quantity of antibody detected 
with anti-Fab vs. the amount of antibody detected with M  anti-T15 or R  anti- P.  J.  GEARHART,  N.  H.  SIGAL,  AND  N.  R.  KLINMAN 
TABLE  III 
Idiotypic Identification of Anti-PC Clones in Various Strains 
881 
Strain  Idiotypic identification 
Nanograms detected  by* 
Anti-Fab  R anti-T15  M anti-T15 
BALB/c clone 
AKR  clone 
A/He  clone 
C3H  clone 
a  R T15+,  M T15+  4.5  5.6  5.4 
b  R T15-, M T15-  10.0  0  0 
c  R T15+-, M T15-  +  8.0  4.0  3.0 
d  R T15+,  M T15-  4.8  3.7  0 
e  R T15+,  M T15-+-  5.2  5.0  1.6 
a  R T15+,  M T15+  12.4  13.0  15.5 
b  R T15-, M T15-  19.0  0  0 
c  R T15_, M T15_  8.0  3.3  4.0 
a  R T15+, M T15-  12.0  10.5  0.9 
b  R T15-, M T15-  20.0  0.2  0.1 
c  R T15-  +, M T15-  +  8.4  4.9  3.8 
a  R T15+,  M T15-  1.0  1.1  0.2 
b  R T15-, M T15-  8.6  0.8  0.6 
c  R T15-+-, M T15-  +  5.6  2.4  1.2 
* The data represent assays of representative monoclonal antibodies  with the various detecting 
reagents that were quantified by comparison with T15 protein. 
T15. The majority of monoclonal antibodies fell into two areas, the T15-negative 
clones in region A  and the T15-positive clones in region C. 
In most of the experiments reported here, limiting dilution cell doses yielded 
between 5 and 20% positive fragments. Since homing of the donor cells follows a 
Poisson  distribution  (25),  a  small  percentage  of the  positive  fragments  from 
recipient mice receiving many cells may contain more than a  single precursor 
cell. The amount of antibody detected with anti-Fab would be greater than that 
detected with anti-idiotype if one of the precursor cells produced the T15 idiotype 
whereas the second precursor cell in the fragment did not. The expected number 
of such double fragments, i.e. predicted overlap, can be calculated by multiply- 
ing the frequency of foci which produce the T15 idiotype by the frequency of foci 
which produce non-T15 antibody (see reference 26 for the validation of independ- 
ent  precursor  distribution  in  fragments).  Foci  producing  partially  idiotypic 
reactive  antibody  were  placed  in  both  categories  since  these  fragments  may 
contain  both  T15-positive  and  negative  precursors.  Therefore,  the  predicted 
overlap  of  17  in  Fig.  l a  was  derived  by  multiplying  the  total  number  of 
fragments by the product  of the  frequency of clones reactive with  M  anti-T15 
(327  +  71 foci in 8,784 fragments) times the frequency of foci with partial or no 
T15 reactivity  (311  +  71  in 8,784  fragments).  This calculated  number presum- 
ably  represents  the  number  of fragments  that  may  contain  more  than  one 
randomly lodged precursor cell. 
In  Fig.  l a  and  b,  the  actual  number  of clones  that  experimentally  fall  in 
region B  (71 and 75) is seen to be greater than the predicted overlap frequency 
(17 and 18), which indicates that some partially reactive antibodies have arisen 882  MONOCLONAL  ANTI-PHOSPHORYLCHOLINE  ANTIBODY  RESPONSE 
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FIG.  1.  Classification of BALB/c anti-PC clones from nonimmune and immune donors by 
Fab/idiotype ratios. Fig. 1 a  represents data plotted according to the ratio of nan•grams of 
antibody detected by anti-Fab vs. M anti-T15; 1 b represents data determined as the ratio of 
antibody detected with anti-Fab compared to R anti-T15. Monoclonal antibodies in region A 
had a  ratio of Fab/idiotype of ->5/1  (idiotype negative); those in region B  were plotted as 
indicated;  antibodies  in  region  C  had  a  ratio  of  1.4/1  or  less  (idiotype  positive).  The 
experimental number of points in group B are noted. The number of points in region B that 
was predicted as the expected overlap in a fragment of two clones, one T15+ and the other 
T15-, was calculated by multiplying the frequency of total foci containing the T15 idiotype 
plus partially reactive antibody (C +  B) by the frequency of foci producing non-T15 antibody 
plus partially reactive antibody (A +  B). The product of the frequencies was multiplied by 
the total number of fragments to yield the number of fragments that may contain more than 
one anti-PC clone. 
from single B cells and constitute a subset of clonotypes. Partial cross-reactions 
could be explained by the heterogeneous nature of the anti-idiotypic antibody. 
For example, if the anti-idiotype contains three types of antibody directed to 
three theoretical determinants on the T15 molecule, a clone producing homoge- 
neous antibody with one such idiotypic determinant would compete one-third as 
well with '2'~I-labeled T15 molecules for the anti-idiotypic sites in the inhibition 
assay. Therefore, the presence of partially cross-reactive antibody in low fre- 
quency experiments where biclonal fragments are not expected to occur may 
serve as a  means of identifying new clonotypes. 
The similarity of  patterns in Fig. 1 a and b suggest that both R T15 and M T15 
idiotypic determinants are either absent, present,  or partially present on the P.  J.  GEARHART,  N.  H.  SIGAL,  AND  N.  R.  KLINMAN  883 
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FIG.  2.  Identification of a subset of BALB/c anti-PC clones by idiotype content. The data 
from monoclonal antibodies with reactivity for T15 in areas B and C shown in Fig.  1 was 
plotted  according  to  the  ratio  of  nanograms  detected  with  R  anti-T15  vs.  nanograms 
detected with M  anti-T15. A  value of -<1.4/1 indicates equal expression of both R T15 and 
M  T15 idiotypic determinants on the same molecule,  whereas a  ratio greater than 1.411 
suggests unequal representation by weight of the two determinants per molecule. 
same clonal product. Thus the ratio of antibody detected with R anti-T15 vs. the 
amount of antibody detected with  M  anti-T15  should  be  1  if the  idiotypic 
determinants are equally represented on the same molecule. As shown in Fig. 2, 
the majority of T15-positive  clones and partially positive clones reacted equally 
well with both anti-idiotypes. However, a  minority of clones non-reciprocally 
expressed the idiotypic determinants which were detected by R anti-T15 and M 
anti-T15. Thus, the R anti-T15/M anti-T15 ratio was significantly greater than 
one for 13 clones which showed reproducibly higher reactivity with R anti-T15 
than with M  anti-T15  on a  weight basis  (Fig.  2).  The bimodal distribution 
reflects two subsets of clones which are described in Table II, that is, some of the 
clones (upper half of Fig. 2) reacted equally well with anti-Fab and R anti-T15 
but had no reaction with M anti-T15 (R T15+, M T15-), and others (lo.wer half 
of Fig. 2) were completely  reactive with anti-Fab and R anti-T15 and had partial 
reactivity for M  anti-T15  (R  T15+,  M  T15_+). This  implies that  the  R  T15 
determinant(s) which is specific for the binding-site region can be present on 
some antibody molecules independently of the M T15 determinants. 
The heterogeneity  of the BALB/c PC-specific repertoire was further analyzed 
by the inhibition of the binding of monoclonal antibodies to PC-BSA-bromoace- 884  MONOCLONAL  ANTI-PHOSPHORYLCHOLINE  ANTIBODY  RESPONSE 
tyl cellulose with 7 × 10  -4 M PC. This technique was used both as a very crude 
estimate of antibody-binding affinity as  well as  a  way to further delineate 
subsets of clonotypes. Although binding of the R T15 +, M T15+ antibody from 
BALB/c mice as well as T15 myeloma protein was completely inhibited at this 
concentration, the T15-negative foci appeared heterogeneous in their binding 
properties (Fig. 3), representing both high and low affinity antibody. Thus, by 
both hapten inhibition and anti-idiotypic reactivity, the T15-negative BALB/c 
antibodies probably represent a heterogeneous array of clonotypes. 
A third approach to assessing the heterogeneity of the BALB/c PC-specific 
repertoire  utilized  an  analysis  of 141  T15-negative foci for  the  presence  of 
antibody reactive with anti-McPC 603 antiserum. No monoclonal antibody was 
found that was reactive with anti-McPC 603 and anti-Fab on a 1:1 weight basis, 
but two foci were detected which exhibited partial (10-20%) cross-reaction with 
this anti-idiotype. The finding that less than 2% of the non-T15 clonotypes share 
this specificity is a  further reflection of the heterogeneity of the non-T15 PC- 
specific B-cell repertoire. 
Analysis of Clonotype Heterogeneity in Other Strains.  PC-specific monoclonal 
antibodies from nonimmune and immune A/He, AKR, and C3H donors were 
assayed with anti-Fab and the two anti-idiotypic reagents. In Table IV, the data 
is expressed as the ratio of nanograms of antibody detected with anti-Fab vs. 
nanograms of antibody detected with R anti-T15 or M anti-T15, where a ratio of 
---5/1 is considered idiotype negative and -< 1.4/1 is idiotype positive. All three 
strains have a significant percentage of antibody that is as reactive with R anti- 
T15 as with anti-Fab, as well as clones that do not have this idiotypic determi- 
nant. The hapten inhibition data in Fig. 3 again demonstrates the heteroge- 
neous nature  of this group of T15-negative clones in AKR,  A/He,  and C3H 
strains. 
In all instances, the number of R T15 idiotype cross-reactive clones exceeds 
the  predicted number of fragments that  could contain two precursors,  one 
idiotype positive and one idiotype negative. Clones partially reactive with M 
anti-T15 are also observed in a  higher frequency than that predicted by the 
number of fragments which could contain two clones. These antibodies exhibited 
partial reactivity with R anti-T15 as well. While it is difficult to interpret the 
relationship between idiotypic cross-reactivity and antibody structure, the par- 
tially reactive antibodies from AKR, A/He, C3H, and BALB/c mice seem to be 
the clonal product of single precursor cells and tentatively can be identified by 
patterns  of cross-reactivity.  Variable  region  genes  coding for  cross-reactive 
idiotypic  determinants  on  antibodies  have  been  reported  and  genetically 
mapped by others (10). 
21 foci from AKR mice were found that reacted equally well with anti-Fab and 
M anti-T15 on a weight basis. Antibody from each of these clones also reacted 
equally well with R anti-T15 as with anti-Fab, and by these criteria of variable 
region idiotypic expression were indistinguishable from T15.  This particular 
clonotype was absent from A/He and C3H nonimmune and immune precursor 
cells. 
Frequency Analysis of Identifiable Clonotypes.  Table V lists the frequency of 
PC-specific  B  cells  from  nonimmune donors  in  each  subpopulation that  is P.  J.  GEARHART,  N.  H.  SIGAL,  AND  N.  R.  KLINMAN  885 
Z 
0 
I-- 
03 
-i- 
Z 
z 
I-- 
0_ 
I 
I00 
50 
BALB/c 
00(15)  •(7) 
I 
AKR 
0(2) 
A/He  C3H 
•  (3) 
| 
-(10)  ._(2)  ~(2}  : 
R  TI5+  R  TIS-  R  TIS-  R  TI5-  R  T|5- 
M  TI5+  M  TI5-  M  TIS-  M  TI5-  M  TI5- 
Fro.  3.  Hapten inhibition of binding of murine monoclonal antibodies to PC-BSA-bromo- 
acetyl cellulose.  Antibody previously determined to be either idiotype positive by both R 
anti-T15 and M anti-T15 (R T15+, M T15+) or negative (R T15-, M T15-) was tested for 
inhibition of its binding to PC-BSA-bromoacetyl cellulose by 7 x  10 -4 M PC in the radioim- 
munoassay.  Q, purified T15 protein; O, individual monoclona] antibodies. 
TABL~  IV 
Analysis of Murine Anti-PC Monoclonal Antibodies by Fab and Idiotypic Reactivity* 
Strain 
ng Fab/ng R T15  ng Fab/ng M T15 
~5  5-1.4  ~1,4  ~5  5-1.4  ~1.4 
Number of foci 
AKR  36  17  21  41  12  21 
A/He  42  11  10  59  4  0 
C3H  21  5  2  27  1  0 
* Antibody from nonimmune and immune donors is expressed  as the ratio of Fab/idiotype by 
weight. Values greater or equal to 5/1 are classified as idiotype negative, and ratios of 1.4/1 or 
less are termed idiotype positive.  The number of partially reactive clones with antibody that 
exhibited some, but not complete, activity in anti-idiotype assays is indicated. 886  MONOCLONAL  ANTI-PHOSPHORYLCHOLINE  ANTIBODY  RESPONSE 
TABLE  V 
Frequency of PC-Specific B-Cell Subpopulations Defined by 
Idiotype in Nonimmune Mice 
Strain 
Precursors/10  s B cells belonging to idiotypic 
subsets 
R T15+  R T15-  R T15+  R T15- 
M T15+  M T15-  M T15-  M T15± 
BALB/c  16.7  4.7  0.2*  1.4 
AKR  2.7  2.7  <0.1  3.7 
A/He  <0.4  4.5  2.0  2.0 
C3H  <0.3  7.9  1.9  2.7 
* The frequency of another BALB/c subset, described in Table III  as 
R T15+,  M T15±, is also 0.2. 
defined by R anti-T15 and M anti-T15 idiotypic analyses. Keeping in mind the 
hapten inhibition data presented in Fig. 3, these results imply a diverse array of 
specificities within the PC-specific repertoire since many unique clonotypes may 
exist within each subpopulation. For example, the R T15-, M T15- group most 
likely represents many clonotypes with idiotypic determinants other than T15. 
Table  V  also  demonstrates that  murine strains  other than  BALB/c do  not 
possess a dominant antibody specificity such as the R T15+, M T15+ clonotype, 
which constitutes  75%  of the  BALB/c  response.  In  fact,  the  corresponding 
clonotype within the AKR repertoire is present in a  lower frequency, which 
suggests that genetic factors may be responsible for the clonal dominance of the 
T15 clone in BALB/c rather than affinity of the antibody for antigen. In A/He 
and C3H mice, the R T15+, M T15- clonotype represents a minor proportion of 
the PC-specific repertoire, although antibody with these characteristics has 
been reported by  others  to  predominate the  sera  of mice  immunized with 
pneumococcus containing the PC determinant (17). 
Discussion 
Intense interest in the analysis of  the immunoglobulin variable region has led 
to widespread use of anti-idiotypic sera as genetic markers for this region. It is 
increasingly clear, however, that not all antisera recognize the same determi- 
nants within the variable region, nor do they necessarily discriminate among 
antibody molecules which have similar but not identical amino acid sequences. 
For example, an anti-idiotypic system has been defined by Claflin and Davie 
(27) which shows cross-reactions among PC-binding myeloma proteins with 
widely differing amino acid sequences. On the other hand, Hart et al.  (9) have 
prepared anti-idiotypic sera which can discriminate between anti-azobenzene- 
arsenate antibodies of individual mice within the same strain. 
Since anti-idiotypic sera can recognize a variety of determinants and can vary 
in their ability to discriminate between closely related clonotypes, every antise- 
rum must be defined within the context of  the experimental system under study. 
This  is  particularly relevant when an  analysis of idiotypic relationships  of 
serum antibodies among strains is undertaken. The detection of low levels of an 
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population of antibodies, none of which are identical to the idiotype in question, 
or alternatively, the relevant idiotype may be present but represent only a small 
proportion of the serum antibody (28). The analysis of homogeneous antibodies 
generated in the splenic focus system provides an unambiguous determination 
of the presence or absence of a given clonotype and its representation within the 
responding B-cell pool. In addition, the partial reactivity of anti-idiotypic anti- 
bodies with a monoclonal antibody permits the identification of new clonotypes 
and has allowed us to uncover interesting relationships among anti-PC antibod- 
ies of BALB/c and other murine strains. Under conditions of individual B-cell 
stimulation in a  milieu of excess carrier-primed T  cells, we have previously 
determined the frequency of the dominant clonotype in the BALB/c PC-specific 
response as about 1/60,000 B cells and demonstrated the existence of non-T15 
idiotype producing PC-specific clones (3, 6). This report extends the characteri- 
zation  of M  anti-T15-positive clones by demonstrating that  (a)  all  BALB/c 
monoclonal antibodies possessing the M anti-T15 idiotypic determinant express 
the  R  anti-T15  idiotype  as  well,  and  (b)  T15  idiotype-positive monoclonal 
antibodies have similar hapten-binding (inhibition) properties. These character- 
istics,  in addition to the isoelectric focusing pattern shared by T15  idiotype- 
positive monoclonal antibodies (4), indicate that the precursors of these clones 
belong to a single clonotype. 
In BALB/c mice, it was possible to demonstrate a heterogeneous array of PC- 
specific clonotypes by anti-idiotypic reactivity and hapten inhibition of antibody 
binding to antigen. For example, the R anti-T15 assay has identified a subset of 
specificities that are not as reactive with M anti-T15 as with R anti-T15 on a 
weight basis.  These antibodies apparently represent several clonotypes since 
they display heterogeneity  by degree of  cross-reactivity  with M anti-T15 (Fig. 2). 
A maximum estimate of the frequency of this entire subset can be calculated to 
be one in  2  ×  106  B  cells,  or 30-40  times fewer than the R T15+,  M  T15+ 
clonotype which is represented by 1 in every 60,000 B cells. Another example of 
idiotypic identification of low frequency clonotypes in BALB/c mice is demon- 
strated by the use of anti-McPC 603 raised in A/He mice. In an analysis of 141 
monoclonal antibodies,  two foci were found that partially cross-reacted with 
anti-McPC 603. While this result indicates that there were no PC-specific clones 
reacting on a 1:1 basis with both anti-McPC 603 and anti-Fab, a new clonotype 
subset is operationally defined on the basis of this cross-reaction. The frequency 
of this subset is approximately 1-2 in 107 B cells.  Furthermore, hapten inhibi- 
tion studies have revealed a wide range of affinities among non-T15 antibodies, 
which suggest the existence of many distinct antigen-combining sites for PC. 
Thus,  by  idiotypic analysis  and  hapten  inhibition,  the  BALB/c  PC-specific 
repertoire consists of a  single predominant clonotype and a  diverse array of 
others. 
Dissection of the PC-specific repertoire of other murine strains with R anti- 
T15  and M anti-T15  reveals that no strain other than BALB/c  has a  single 
predominant clonotype. The frequency  of PC-specific B cells in AKR, A/He, and 
C3H  mice is about  1 in  100,000 B  cells compared to  1 in  50,000 in BALB]c. 
Although the repertoire in these strains is more difficult to define precisely, it is 
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reactions. Some monoclonal antibodies were recognized by neither anti-idiotype, 
some cross-reacted weakly with both R anti-T15 and M anti-T15, and some were 
identified as R T15+ and M T15-. The R T15-, M T15-  and R T15-  +, M T15 +_ 
subsets each  apparently  represent  several  clonotypes since  antibodies  in  the 
former group show diversity in their affinity for hapten,  and those in the latter 
group  vary in their  reactivity with both anti-idiotypic  preparations.  The  low 
levels of M anti-T15 reactivity seen by others (13) in the serum of A/He and C3H 
mice were apparently  due to weak cross-reactions  among  a  diverse  antibody 
population rather than to the presence of a low frequency of molecules idiotypi- 
cally identical to T15. 
Serum  antibody from AKR,  A/He,  and  C3H mice had  been reported to be 
homogeneous by binding characteristics and complete reactivity with R anti-T15 
but not with M anti-T15 (17), although more recent work suggested that several 
more clones are involved (5).  Monoclonal antibodies with these characteristics 
(R T15+,  M T15-) were found at a  frequency of 1/500,000  B cells in A/He and 
C3H mice; however, this clonotype represented only 20% of the nonimmune  B 
cells specific for PC,  with the other 80% appearing quite diverse.  Thus,  under 
conditions of individual  B-cell stimulation  in the  splenic focus system with a 
hapten-carrier  complex which maximizes T-cell participation in stimulation,  a 
diverse  array  of specificities is stimulated.  The  existence  of a  heterogeneous 
array of non-T15 idiotype-producing cells in BALB/c mice has been revealed by 
the  same  techniques,  emphasizing  the  value  of this  assay  in  detecting  the 
majority of cells capable of being stimulated by a  given antigen  (3). 
The T15 clonotype in BALB/c mice is unique  compared to other clonotypes 
which are specific for PC in other murine stains. The frequency of the R T15+, 
M T15- subset in AKR, A/He, and C3H is at least 10-fold lower than the predomi- 
nant clonotype in BALB/c. Furthermore,  in the specificity repertoires of B cells 
responsive to a ,variety of determinants including dinitrophenyl (29), 4-hydroxy- 
5-iodo-3-nitrophenacetyl (30),  and PC, the T15 clonotype in BALB/c mice is the 
only clonotype identified with such a high frequency. This observation implies 
that the frequency of the T15 clonotype may not be representative of the entire 
repertoire. Whatever mechanism is responsible for the unusually high represen- 
tation of this clonotype in BALB/c mice, it is unlikely that antigen contact plays 
a role in the expansion of the T15 clonotype, since the frequency is the same in 
germfree and conventionally reared donors (6). 
In AKR mice, a group of clones reacts equally well with anti-Fab, R anti-T15, 
and M anti-T15.  These monoclonal antibodies would thus appear to be idiotypi- 
cally indistinguishable  from the T15 clonotype in the BALB/c strain.  Previous 
genetic studies have failed to reveal the presence of the M T15 idiotype in AKR 
mice (13, 17, 31). Although Table I demonstrates that the M anti-Tl5 serum used 
in this study is similar by several criteria to that used by other investigators,  a 
possible explanation for the detection of T15-positive clones in AKR mice is that 
this antiserum has some properties which differ from those defined previously. 
It should be noted that preliminary analysis indicates cross-reactivity of this M 
anti-T15 serum with the MOPC 511 PC-specific myeloma protein, a finding also 
reported by Lieberman and Potter for their M anti-T15 sera (32). Nevertheless, a 
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this idiotypic similarity is due to the complete sharing of variable region genes 
between these allotypically distinct strains will only be discerned by the amino 
acid sequence analysis of the AKR monoclonal antibody. 
Since the AKR T15-positive  clonotype is found in every individual of the 
strain,  it presumably reflects a  germ line antibody specificity. However, the 
frequency of the AKR clonotype is 2.7/10  6 B cells, or sixfold lower than the 
frequency of the idiotypically similar BALB/c T15 clonotype, implying that not 
all  specificities represented in  the  germ line  need be  expressed  at  a  high 
frequency. The mechanism responsible for the differential expression of similar 
antibody specificities in allotypically distinct strains may lead to an understand- 
ing of the role of regulatory genes in variable region expression and of the 
phenomenon of clonal dominance. 
In addition to providing insights into the heterogeneity and expression of the 
murine B-cell repertoire, these studies point out fine structural relationships 
between PC-specific clonotypes. It is clear that the PC-specific B-cell repertoire 
of C3H,  A/He, AKR, and BALB/c mice share variable region determinants to 
varying extents. The retention of some variable region determinants in strains 
differing in allotype may imply strong selective pressure for retention of certain 
specificities. This conclusion is best exemplified by the finding of the R T15 
idiotypic determinant on BALB/c monoclonal antibodies with and without reac- 
tivity to  M  anti-T15.  The  identification of idiotypic determinants in  some 
antibodies in conjunction with M T15 idiotypic determinants and independently 
on others has important implications for the genetic relationship between the 
two determinants. The occurrence of the T15 clonotype in high frequency in 
every individual of the BALB/c strain suggests that determinants detected by 
both anti-idiotypic preparations are encoded in the germ line. The presence of R 
T15+, M T15-antibody in BALB/c may indicate that this combining site or very 
similar sites can be associated with other framework sequences as well. If this 
binding site amino acid sequence is important for the survival of the organism, 
as suggested by its conservation within the species, it would be logical to assume 
that it may be associated with framework  residues other than the one defined by 
M anti-T15. This expression may be the result of the fortuitous generation of 
similar variable region determinants either evolutionarily (gene duplication 
and segregation) or somatically (e.g., via episomal insertion [14]). Amino acid 
sequence analysis  of the  R  T15+,  M  T15-  monoclonal antibodies  may be 
essential for discriminating between these possibilities. 
Summary 
The idiotypic identification of monoclonal antibodies has been used to define 
and enumerate clonotypes within the murine repertoire of B cells specific for 
phosphorylcholine (PC). The response in the BALB/c strain is dominated by a 
single  antibody specificity which is  identical to  TEPC  15  protein;  however, 
antibody without the  TEPC  15  idiotype appears  heterogeneous by idiotypic 
cross-reactivity and hapten inhibition of binding to antigen. Dissection of the 
PC-specific repertoire in the AKR, A/He, and C3H strains has indicated that 
some  monoclonal antibodies  share  binding-site  idiotypic determinants with 
TEPC 15, although these clones represent a minority of the precursor cells. 890  MONOCLONAL  ANTI-PHOSPHORYLCHOLINE  ANTIBODY  RESPONSE 
In addition to providing insights into the heterogeneity and expression of the 
murine B-cell repertoire, these studies emphasize structural relationships be- 
tween PC-specific clonotypes. Within the BALB/c strain, some antibodies share 
combining-site-related idiotypic specificities with TEPC 15, but differ in other 
variable region determinants. Among allotypically  distinct strains, there exists 
a remarkable similarity of  variable region determinants in at least a minority of 
antibodies. 
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acknowledged. 
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